Current therapy of hypoparathyroidism - A survey of German endocrinology centers

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue 4, 1997, Pages 237-241

  Schilling, T ^a   Ziegler, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hypoparathyroidism therapy; Vitamin D

Indexed keywords

ALFACALCIDOL; CALCITRIOL; COLECALCIFEROL; DIHYDROTACHYSTEROL; VITAMIN D;

ADULT; AGED; ARTICLE; GERMANY; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VITAMIN D INTOXICATION;

EID: 0030921765     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211759     Document Type: Article

References (16)

1. Ali AA, Varghese Z, Moorhead JF, Baillod RA, Sweny P: Calcium set point progressively worsens in hemodialysis patients despite conventional oral I-alpha hydroxycholecalciferol supplementation. Clin-Nephrol 39: 205-209, 1993
2. Bothe V, Schmidt-Gayk H, Armbruster FP, Mayer E: Assay for the diagnosis of hyper- and hypovitaminosis. D Ärztl Lab 30: 151-156, 1984
3. Chase LR, Melson GL, Aurbach GD: Pseudohypoparathyroidism: defective excretion of 3′,5′-AMP in response to parathyroid hormone. J Clin Invest 48: 1832-1844, 1969
4. Drezner MK, Neelon FA, Lebovitz HE: Pseudohypoparathyroidism type II. A possible defect in the reception of the cyclic AMP signal. N Engl J Med 289: 1056-1060, 1983
5. Gallacher SJ, Cowan RA, Fraser WD, Logue FC, Jenkins A, Boyle IT: Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man. Eur J Endocrinol 130: 141-145, 1994
6. 3 therapy. Clin Endocrinol Oxf 40: 303-307, 1994
7. Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT: Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310: 358-363, 1995
8. Heyburn PJ, Peacock M: The management of hypoparathyroidism with 1α-hydroxyvitamin D3. Clin Endocrinol 7, Suppl: 209-214, 1977
9. Jørgensen H, Vogt JH: 1α-hydroxycholecalciferol in the treatment of hypoparathyroidism. Acta Med Scand 201: 3-7, 1977
10. Kidd GS, Schaaf M, Adler RA, Lassman MN, Wray HL: Skeletal responsiveness in pseudohypoparathyroidism: A spectrum of clinical disease. Am J Med 68: 772-781, 1980
11. Lewin IG, Paparpoulos SE, O'Riordan JLH: 1α-hydroxyvitamin D3 in the long-term management of hypoparathyroidism and pseudohypoparathyroidism. Clin Endocrinol 7, Suppl: 203-207, 1977
12. 3) and calcium in osteoporosis. Clin-Orthop 300: 241-247, 1994
13. Schilling T, Ziegler R: Aktuelle Diagnostik und Therapie des Hypoparathyreoidismus. Dtsch Med Wochenschrift 121: 841-844, 1996.
14. Ziegler R: Behandlung des Hypoparathyreoidismus - womit? Deutsches Ärzteblatt 38A: 2667-2668, 1989
15. Ziegler R: Die Therapie des tetanischen Syndroms. Dtsch med Wschr 110: 424-427, 1985
16. Ziegler R, Minne H, Raue F, Paar G, Delling G: Beobachtungen zur Vitamin-D- und Dihydrotachysterin-Vergiftung. Dtsch med Wschr 100: 415-423, 1975